"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. . "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. eflornithine. this classification denotes an ornithine decarboxylase inhibitor with the molecular formula c6h12f2n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zqn1g5v6sr, chemically known as 2,5-diamino-2-(difluoromethyl)pentanoic acid but generally known as eflornithine, which bears us nih compound identifier 3009. european medicines agency schedules eflornithine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06468mig. the term eflornithine is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules eflornithine in its anatomical therapeutic chemical (atc) classification. eflornithine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule eflornithine under hs 29224995 and sitc 51465. as of q4 2014, eflornithine remains the us fda preferred term for this commodity. eflornithine bears us nlm identifiers umls id c0086156 and nci concept code c226. smiles: fc(f)c(n)(cccn)c(=o)o.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. meglumine antimonate. this classification denotes an antihelminthic agent with the molecular formula c7h18no8sb, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 75g4tw236w, chemically known as hydroxy(dioxo)-?5-stibane;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol but generally known as meglumine antimonate, which bears us nih compound identifier 64953. european medicines agency schedules meglumine antimonate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12915mig. world health organization schedules meglumine antimonate in its anatomical therapeutic chemical (atc) classification. most nations schedule meglumine antimonate under hs 29221980 and sitc 51461. smiles: cncc(c(c(c(co)o)o)o)o.o[sb](=o)=o.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. calcium oxide. this classification denotes a dental material with the molecular formula ca.o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c7x2m0vvnh, chemically known as lime, burned but generally known as calcium oxide, which bears us nih compound identifier 14778. european medicines agency schedules calcium oxide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13189mig. most nations schedule calcium oxide under hs 28259000 and sitc 52269. smiles: o=[ca].. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. polynoxylin. this classification denotes an antihelminthic agent with the molecular formula c2h6n2o2, chemically known as formaldehyde;urea but generally known as polynoxylin, which bears us nih compound identifier 62705. european medicines agency schedules polynoxylin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03939mig. the term polynoxylin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5.). world health organization schedules polynoxylin in its anatomical therapeutic chemical (atc) classification. polynoxylin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule polynoxylin under hs 39091000 and sitc 57541. smiles: c=o.c(=o)(n)n.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. pentamidine. this classification denotes an antiprotozoal agent and antifungal with the molecular formula c19h24n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 673lc5j4lq, chemically known as 4,4-(pentamethylenedioxy)dibenzamidine but generally known as pentamidine, which bears us nih compound identifier 4735. european medicines agency schedules pentamidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09682mig. the term pentamidine is an international non-proprietary name. pentamidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pentamidine under hs 29252900 and sitc 51482. as of q4 2014, pentamidine remains the us fda preferred term for this commodity. pentamidine bears us nlm identifiers umls id c0030863 and nci concept code c731. smiles: o(cccccoc1ccc(cc1)c(=n)n)c1ccc(cc1)c(=n)n.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. diloxanide furoate. this classification denotes an antiparasitic agent with the molecular formula c9h9cl2no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 89134scm7m, chemically known as 2,2-dichloro-4-hydroxy-n-methylacetanilide but generally known as diloxanide, which bears us nih compound identifier 11367. european medicines agency schedules diloxanide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07147mig. the term diloxanide is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules diloxanide in its anatomical therapeutic chemical (atc) classification. diloxanide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule diloxanide furoate under hs 29242995 and sitc 51479. as of q4 2014, diloxanide furoate remains the us fda preferred term for this commodity. smiles: clc(cl)c(=o)n(c1ccc(o)cc1)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. melarsoprol. this classification denotes a trypanocidal agent and arsenical with the molecular formula c12h15asn6os2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zf3786q2e8, chemically known as 1,3,2-dithiarsolane-4-methanol, 2-(4-((4,6-diamino-1,3,5-triazin-2-yl)amino)phenyl)- but generally known as melarsoprol, which bears us nih compound identifier 10311. european medicines agency schedules melarsoprol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08721mig. world health organization schedules melarsoprol in its anatomical therapeutic chemical (atc) classification. melarsoprol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule melarsoprol under hs 29349990 and sitc 51579. as of q4 2014, melarsoprol remains the us fda preferred term for this commodity. smiles: c1c(s[as](s1)c2=cc=c(c=c2)nc3=nc(=nc(=n3)n)n)co.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. taurolidine. this classification denotes an antibiotic with the molecular formula c7h16n4o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8obz1m4v3v, chemically known as 4,4-methylenebis(tetrahydro-1,2,4-thiadiazine 1,1-dioxide) but generally known as taurolidine, which bears us nih compound identifier 29566. european medicines agency schedules taurolidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10837mig. the term taurolidine is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules taurolidine in its anatomical therapeutic chemical (atc) classification. taurolidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule taurolidine under hs 29349990 and sitc 51579. as of q4 2014, taurolidine remains the us fda preferred term for this commodity. taurolidine bears us nlm identifiers umls id c0144567 and nci concept code c2639. smiles: s1(=o)(=o)ncn(cn2ccs(=o)(=o)nc2)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. iodoquinol. this classification denotes an antiprotozoal agent with the molecular formula c9h5i2no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 63w7ie88k8, chemically known as 5,7-diodo-8-quinolinol but generally known as diiodohydroxyquinoline, which bears us nih compound identifier 3728. european medicines agency schedules diiodohydroxyquinoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07142mig. the term diiodohydroxyquinoline is an international non-proprietary name. world health organization schedules diiodohydroxyquinoline in its anatomical therapeutic chemical (atc) classification. as of q4 2014, iodoquinol remains the us fda preferred term for this commodity. iodoquinol bears us nlm identifiers umls id c0012341 and nci concept code c76008. smiles: ic1c2c(nccc2)c(o)c(i)c1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. trimetrexate. this classification denotes a folate antagonist and dihydrofolate reductase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier upn4iti8t4. european medicines agency schedules trimetrexate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11312mig. trimetrexate generally arises in the molecular formula c19h23n5o3. the term trimetrexate is an international non-proprietary name or inn. trimetrexate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trimetrexate under hs 29335995 and sitc 51576. as of q4 2014, trimetrexate remains the us fda preferred term for this commodity. trimetrexate bears us nlm identifiers umls id c0085176 and nci concept code c1314. smiles: o(c1cc(ncc2c(c3c(nc([nh]c3n)n)cc2)c)cc(oc)c1oc)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. propamidine. this classification denotes an antiprotozoal agent with the molecular formula c17h20n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g20g12v769, chemically known as 4,4-(trimethylenedioxy)dibenzamidine but generally known as propamidine, which bears us nih compound identifier 64949. european medicines agency schedules propamidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10095mig. the term propamidine is an international non-proprietary name. world health organization schedules propamidine in its anatomical therapeutic chemical (atc) classification. propamidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule propamidine under hs 29252900 and sitc 51482. as of q4 2014, propamidine remains the us fda preferred term for this commodity. propamidine bears us nlm identifiers umls id c0072159 and nci concept code c82250. smiles: o(cccoc1ccc(cc1)c(=n)n)c1ccc(cc1)c(=n)n.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. amprolium. this classification denotes an antiparasitic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 95co6n199q. european medicines agency schedules amprolium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05489mig. amprolium generally arises in the molecular formula c14h19cln4. the term amprolium is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7.) amprolium is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amprolium under hs 29335995 and sitc 51576. as of q4 2014, amprolium remains the us fda preferred term for this commodity. amprolium bears us nlm identifiers umls id c0002686 and nci concept code c76388. smiles: [n]1(cc2c(nc(nc2)ccc)n)c(cccc1)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. antienite. this classification denotes an antihelminthic agent with the molecular formula c9h8n2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 50z1jvp72h, chemically known as imidazo(2,1-b)thiazole, 5,6-dihydro-6-(2-thienyl)-, ( -)- but generally known as antienite, which bears us nih compound identifier 170351. european medicines agency schedules antienite in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05529mig. the term antienite is an international non-proprietary name. antienite is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule antienite under hs 29349990 and sitc 51579. as of q4 2014, antienite remains the us fda preferred term for this commodity. antienite bears us nlm identifiers umls id c2346831 and nci concept code c74151. smiles: s1c2=nc(cn2cc1)c1sccc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. arsthinol. this classification denotes an antiprotozoal agent with the molecular formula c11h14asno3s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qnt09a162y, chemically known as 2-hydroxy-5-(4-hydroxymethyl-1,3,2-dithiarsolan-2-yl)acetanilid but generally known as arsthinol, which bears us nih compound identifier 8414. european medicines agency schedules arsthinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05572mig. the term arsthinol is an international non-proprietary name. world health organization schedules arsthinol in its anatomical therapeutic chemical (atc) classification. arsthinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule arsthinol under hs 29349990 and sitc 51579. as of q4 2014, arsthinol remains the us fda preferred term for this commodity. arsthinol bears us nlm identifiers umls id c0301341 and nci concept code c76411. smiles: cc(=o)nc1=c(c=cc(=c1)[as]2scc(s2)co)o.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. azanidazole. this classification denotes an antiprotozoal agent with the molecular formula c10h10n6o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yp2y0drx4s, chemically known as 2-pyrimidinamine, 4-(2-(1-methyl-5-nitro-1h-imidazol-2-yl)ethenyl)-, (e)- but generally known as azanidazole, which bears us nih compound identifier 6436171. european medicines agency schedules azanidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05635mig. the term azanidazole is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules azanidazole in its anatomical therapeutic chemical (atc) classification. azanidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azanidazole under hs 29335995 and sitc 51576. as of q4 2014, azanidazole remains the us fda preferred term for this commodity. azanidazole bears us nlm identifiers umls id c0052751 and nci concept code c73274. smiles: cn1c(=cn=c1/c=c/c2=nc(=nc=c2)n)[n+](=o)[o-].. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. benznidazole. this classification denotes an antiprotozoal agent with the molecular formula c12h12n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yc42nrj1zd, chemically known as 1h-imidazole-1-acetamide, 2-nitro-n-(phenylmethyl)- (9ci) but generally known as benznidazole, which bears us nih compound identifier 31593. european medicines agency schedules benznidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05753mig. the term benznidazole is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). world health organization schedules benznidazole in its anatomical therapeutic chemical (atc) classification. benznidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule benznidazole under hs 29332990 and sitc 51573. as of q4 2014, benznidazole remains the us fda preferred term for this commodity. benznidazole bears us nlm identifiers umls id c0053230 and nci concept code c1013. smiles: c1=cc=c(c=c1)cnc(=o)cn2c=cn=c2[n+](=o)[o-].. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. bialamicol. this classification denotes an antiprotozoal agent with the molecular formula c28h40n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ta5nm093qj, chemically known as 5,5-diallyl-alpha,alpha-bis(diethylamino)-n,n-bitolyl-4,4-diol but generally known as bialamicol, which bears us nih compound identifier 10304. bialamicol most often comes in base and hydrochloride forms. european medicines agency schedules bialamicol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05812mig. the term bialamicol is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). bialamicol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bialamicol under hs 29222900 and sitc 51462. as of q4 2014, bialamicol remains the us fda preferred term for this commodity. bialamicol bears us nlm identifiers umls id c0301342 and nci concept code c83555. smiles: oc1c(cn(cc)cc)cc(c2cc(cn(cc)cc)c(o)c(c2)cc=c)cc1cc=c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. clamoxyquin. this classification denotes an antiprotozoal agent with the molecular formula c17h24cln3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jun13fz6rf, chemically known as cn-17,900-2b but generally known as clamoxyquin, which bears us nih compound identifier 18029. european medicines agency schedules clamoxyquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06637mig. the term clamoxyquine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). as of q4 2014, clamoxyquin remains the us fda preferred term for this commodity. clamoxyquin bears us nlm identifiers umls id c2699337 and nci concept code c78097. smiles: ccn(cc)cccncc1=cc(=c2c=cc=nc2=c1o)cl.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. broxyquinoline. this classification denotes an anti-infective agent with the molecular formula c9h5br2no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uk4c618c8t, chemically known as 5,7-dibromooxine but generally known as broxyquinoline, which bears us nih compound identifier 2453. european medicines agency schedules broxyquinoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05940mig. the term broxyquinoline is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules broxyquinoline in its anatomical therapeutic chemical (atc) classification. broxyquinoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule broxyquinoline under hs 29334990 and sitc 51575. as of q4 2014, broxyquinoline remains the us fda preferred term for this commodity. broxyquinoline bears us nlm identifiers umls id c0054157 and nci concept code c73253. smiles: brc1c2c(nccc2)c(o)c(br)c1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. buparvaquone. this classification denotes an antiprotozoal agent with the molecular formula c21h26o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0354rt7lg4, chemically known as 1,4-naphthalenedione, 2-((4-(1,1-dimethylethyl)cyclohexyl)methyl)-3-hydroxy- but generally known as buparvaquone, which bears us nih compound identifier 71768. european medicines agency schedules buparvaquone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05980mig. the term buparvaquone is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). buparvaquone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule buparvaquone under hs 29146990 and sitc 51629. as of q4 2014, buparvaquone remains the us fda preferred term for this commodity. buparvaquone bears us nlm identifiers umls id c0054224 and nci concept code c73276. smiles: oc1=c(cc2ccc(c(c)(c)c)cc2)c(=o)c(=o)c2c1cccc2.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. calcium trisodium pentetate. this classification denotes a metal chelator with the molecular formula c14h18n3o10.ca.3na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g79yn26h5b, chemically known as trisodium (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))calciate(3-) but generally known as calcium trisodium pentetate, which bears us nih compound identifier 6328163. european medicines agency schedules calcium trisodium pentetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13204mig. the term calcium trisodium pentetate is an international non-proprietary name. most nations schedule calcium trisodium pentetate under hs 29224995 and sitc 51465. smiles: [ca]12345oc(=o)cn4(ccn3(ccn5(cc(=o)o2)cc(=o)o)cc(=o)o)cc(=o)o1.[na].[na].[na].. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. carbarsone. this classification denotes an antiprotozoal agent with the molecular formula c7h9asn2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8pk70txe1t, chemically known as benzenearsonic acid, p-ureido- but generally known as carbarsone, which bears us nih compound identifier 8480. carbarsone most often comes in base, oxide, and sodium forms. european medicines agency schedules carbarsone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06116mig. the term carbarsone is an international non-proprietary name. carbarsone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, carbarsone remains the us fda preferred term for this commodity. carbarsone bears us nlm identifiers umls id c0054654 and nci concept code c76414. smiles: [as](=o)(o)(o)c1ccc(nc(=o)n)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. carnidazole. this classification denotes an antiprotozoal agent with the molecular formula c8h12n4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rh5ki819jg, chemically known as carbamothioic acid, (2-(2-methyl-5-nitro-1h-imidazol-1-yl)ethyl)-, o-methyl ester but generally known as carnidazole, which bears us nih compound identifier 3032998. european medicines agency schedules carnidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06133mig. the term carnidazole is an international non-proprietary name. carnidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carnidazole under hs 29332990 and sitc 51573. as of q4 2014, carnidazole remains the us fda preferred term for this commodity. carnidazole bears us nlm identifiers umls id c0054805 and nci concept code c78095. smiles: s=c(oc)nccn1c(ncc1[n](=o)o)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. chiniofon. this classification denotes an antiprotozoal agent with the molecular formula c9h6ino4s.cho3.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 98f8y85b6w, chemically known as 5-quinolinesulfonic acid, 8-hydroxy-7-iodo- but generally known as chiniofon, which bears us nih compound identifier 11042. european medicines agency schedules chiniofon in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12428mig. the term chiniofon is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules chiniofon in its anatomical therapeutic chemical (atc) classification. chiniofon is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule chiniofon under hs 30039010 and sitc 54291. as of q4 2014, chiniofon remains the us fda preferred term for this commodity. chiniofon bears us nlm identifiers umls id c0008129 and nci concept code c76415. smiles: ic1cc(s(=o)(=o)o)c2c(nccc2)c1o.[na].oc(=o)o.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. chlorbetamide. this classification denotes an antiprotozoal agent with the molecular formula c11h11cl4no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3s489rfx0j, chemically known as 2,2-dichloro-n-2,4-dichlorobenzyl-n-2-hydroxyethyl-acetamide but generally known as chlorbetamide, which bears us nih compound identifier 7330. european medicines agency schedules chlorbetamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06177mig. the term chlorbetamide is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). chlorbetamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule chlorbetamide under hs 29242995 and sitc 51479. as of q4 2014, chlorbetamide remains the us fda preferred term for this commodity. chlorbetamide bears us nlm identifiers umls id c2699182 and nci concept code c76416. smiles: c1=cc(=c(c=c1cl)cl)cn(cco)c(=o)c(cl)cl.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. clamoxyquine. this classification denotes an antiprotozoal agent with the molecular formula c17h24cln3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jun13fz6rf, chemically known as cn-17,900-2b but generally known as clamoxyquin, which bears us nih compound identifier 18029. european medicines agency schedules clamoxyquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06637mig. the term clamoxyquine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). most nations schedule clamoxyquine under hs 29334990 and sitc 51575. smiles: ccn(cc)cccncc1=cc(=c2c=cc=nc2=c1o)cl.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. clefamide. this classification denotes an antiprotozoal agent with the molecular formula c17h16cl2n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4az2v8k4ek, chemically known as 2,2-dichloro-n-(2-hydroxyethyl)-n-(p-(p-nitrophenoxy)benzyl)acetamide but generally known as clefamide, which bears us nih compound identifier 71819. european medicines agency schedules clefamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06647mig. the term clefamide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules clefamide in its anatomical therapeutic chemical (atc) classification. clefamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clefamide under hs 29242995 and sitc 51479. as of q4 2014, clefamide remains the us fda preferred term for this commodity. clefamide bears us nlm identifiers umls id c0610174 and nci concept code c78099. smiles: clc(cl)c(=o)n(cc1ccc(oc2ccc([n](=o)o)cc2)cc1)cco.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. clopidol. this classification denotes an antiprotozoal agent with the molecular formula c7h7cl2no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8j763hff5n, chemically known as 3,5-dichloro-4-hydroxy-2,6-dimethylpyridine but generally known as clopidol, which bears us nih compound identifier 18087. european medicines agency schedules clopidol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06739mig. the term clopidol is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). clopidol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clopidol under hs 29333999 and sitc 51574. as of q4 2014, clopidol remains the us fda preferred term for this commodity. clopidol bears us nlm identifiers umls id c0009028 and nci concept code c76417. smiles: clc1c([nh]c(c(cl)c1=o)c)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. dehydroemetine. this classification denotes an antiprotozoal agent with the molecular formula c29h38n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7s79qt1t91, chemically known as 2,3-didehydroemetine dihydrochloride (.+-.)- but generally known as dehydroemetine, which bears us nih compound identifier 17558. european medicines agency schedules dehydroemetine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06946mig. the term dehydroemetine is an international non-proprietary name. dehydroemetine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dehydroemetine under hs 29399900 and sitc 54149. as of q4 2014, dehydroemetine remains the us fda preferred term for this commodity. dehydroemetine bears us nlm identifiers umls id c0011184 and nci concept code c418. smiles: o(c1cc2c3n(cc(=c(c3)cc3nccc4c3cc(oc)c(oc)c4)cc)ccc2cc1oc)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. diclazuril. this classification denotes an antiprotozoal agent with the molecular formula c17h9cl3n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k110k1b1ve, chemically known as r64,433 but generally known as diclazuril, which bears us nih compound identifier 58902. european medicines agency schedules diclazuril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07091mig. the term diclazuril is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). most nations schedule diclazuril under hs 29336980 and sitc 51576. as of q4 2014, diclazuril remains the us fda preferred term for this commodity. diclazuril bears us nlm identifiers umls id c0057874 and nci concept code c76418. smiles: clc1c(c(c2ccc(cl)cc2)c#n)c(cl)ccc1n1ncc(=o)[nh]c1=o.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. difetarsone. this classification denotes an antiprotozoal agent with the molecular formula c14h18as2n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g4g9j3q65w, chemically known as n,n-ethylenediarsanilic acid but generally known as difetarsone, which bears us nih compound identifier 68199. european medicines agency schedules difetarsone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07124mig. the term difetarsone is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules difetarsone in its anatomical therapeutic chemical (atc) classification. difetarsone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, difetarsone remains the us fda preferred term for this commodity. difetarsone bears us nlm identifiers umls id c1322006 and nci concept code c78101. smiles: [as](=o)(o)(o)c1ccc(nccnc2ccc([as](=o)(o)o)cc2)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. fumagillin. this classification denotes an antineoplastic antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7ow73204u1. european medicines agency schedules fumagillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub23269. fumagillin generally arises in the molecular formula c26h34o7. the term fumagillin is an international non-proprietary name or inn. fumagillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fumagillin under hs 29419000 and sitc 54139. as of q4 2014, fumagillin remains the us fda preferred term for this commodity. fumagillin bears us nlm identifiers umls id c0060819 and nci concept code c75963. smiles: o1c(c2c3(oc3)ccc(oc(=o)/c=c/c=c/c=c/c=c/c(=o)o)c2oc)(c1c/c=c(/c)c)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. dinitolmide. this classification denotes a pesticide with the molecular formula c8h7n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier aox68ry4tv, chemically known as 3,5-dinitro-o-toluamide solution but generally known as dinitolmide, which bears us nih compound identifier 3092. european medicines agency schedules dinitolmide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07193mig. the term dinitolmide is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). dinitolmide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dinitolmide under hs 29242995 and sitc 51479. as of q4 2014, dinitolmide remains the us fda preferred term for this commodity. dinitolmide bears us nlm identifiers umls id c0012458 and nci concept code c79128. smiles: o=c(n)c1c(c([n](=o)o)cc([n](=o)o)c1)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. emetine. this classification denotes an antiprotozoal agent with the molecular formula c29h40n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x8d5epo80m, chemically known as 2h-benzo(a)quinolizine, 3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2-((1,2,3,4-tetrahydro-6,7-dimethoxy-1-isoquinolyl)methyl)- but generally known as emetine, which bears us nih compound identifier 9426. european medicines agency schedules emetine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01877mig. world health organization schedules emetine in its anatomical therapeutic chemical (atc) classification. most nations schedule emetine under hs 29399990 and sitc 54149. as of q4 2014, emetine remains the us fda preferred term for this commodity. emetine bears us nlm identifiers umls id c0013974 and nci concept code c81578. smiles: o(c1cc2c3n(cc(c(c3)cc3nccc4c3cc(oc)c(oc)c4)cc)ccc2cc1oc)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. emodepside. this classification denotes an antihelminthic agent with the molecular formula c60h90n6o14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yz647y5gc9. the term emodepside is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46. ). most nations schedule emodepside under hs 29349990 and sitc 51579. as of q4 2014, emodepside remains the us fda preferred term for this commodity. emodepside bears us nlm identifiers umls id c1172566 and nci concept code c90726. smiles: cc1c(=o)n(c(c(=o)oc(c(=o)n(c(c(=o)oc(c(=o)n(c(c(=o)oc(c(=o)n(c(c(=o)o1)cc(c)c)c)cc2=cc=c(c=c2)n3ccocc3)cc(c)c)c)c)cc(c)c)c)cc4=cc=c(c=c4)n5ccocc5)cc(c)c)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. etofamide. this classification denotes an antiprotozoal agent with the molecular formula c19h20cl2n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 03f36jh21u, chemically known as 2,2-dichloro-n-(2-ethoxyethyl)-n-(p-(p-nitrophenoxy)benzyl)acetamide but generally known as etofamide, which bears us nih compound identifier 65718. european medicines agency schedules etofamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07318mig. the term etofamide is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules etofamide in its anatomical therapeutic chemical (atc) classification. etofamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule etofamide under hs 29242995 and sitc 51479. as of q4 2014, etofamide remains the us fda preferred term for this commodity. etofamide bears us nlm identifiers umls id c0059867 and nci concept code c65586. smiles: clc(cl)c(=o)n(cc1ccc(oc2ccc([n](=o)o)cc2)cc1)ccocc.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. ferric cacodylate. this classification denotes an antihelminthic agent with the molecular formula 3c2h6aso2.fe, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zct01nz5hd, chemically known as arsinic acid, dimethyl-, iron(3+) salt but generally known as ferric cacodylate, which bears us nih compound identifier 22273. most nations schedule ferric cacodylate under hs 28444030 and sitc 52519. as of q4 2014, ferric cacodylate remains the us fda preferred term for this commodity. ferric cacodylate bears us nlm identifiers umls id c0991824 and nci concept code c81518. smiles: c[as](=o)(c)[o-].c[as](=o)(c)[o-].c[as](=o)(c)[o-].[fe+3].. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. fexinidazole. this classification denotes an antiprotozoal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 306erl82ir. european medicines agency schedules fexinidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07618mig. fexinidazole generally arises in the molecular formula c12h13n3o3s. the term fexinidazole is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17.) fexinidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fexinidazole under hs 29332990 and sitc 51573. as of q4 2014, fexinidazole remains the us fda preferred term for this commodity. fexinidazole bears us nlm identifiers umls id c0060304 and nci concept code c65680. smiles: cn1c(=cn=c1coc2=cc=c(c=c2)sc)[n+](=o)[o-].. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. forminitrazole. this classification denotes an antiprotozoal agent with the molecular formula c4h3n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gtw8db3ovn, chemically known as formamide, n- (5-nitro-2-thiazolyl)- but generally known as forminitrazole, which bears us nih compound identifier 219073. european medicines agency schedules forminitrazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07786mig. the term forminitrazole is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). forminitrazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule forminitrazole under hs 29341000 and sitc 51579. as of q4 2014, forminitrazole remains the us fda preferred term for this commodity. forminitrazole bears us nlm identifiers umls id c1880843 and nci concept code c65753. smiles: s1c([n](=o)o)cnc1nc=o.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. glycobiarsol. this classification denotes an antiprotozoal agent with the molecular formula c8h9asno5.bi.o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e3u8347qwj, chemically known as bismuth, (hydrogen n-glycoloylarsanilato)oxo- (8ci) but generally known as glycobiarsol, which bears us nih compound identifier 16682839. european medicines agency schedules glycobiarsol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07950mig. the term glycobiarsol is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules glycobiarsol in its anatomical therapeutic chemical (atc) classification. glycobiarsol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, glycobiarsol remains the us fda preferred term for this commodity. glycobiarsol bears us nlm identifiers umls id c0301343 and nci concept code c76421. smiles: [bi](=o)o[as](=o)(o)c1ccc(nc(=o)co)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. halofuginone. this classification denotes an angiogenesis activator inhibitor and alkaloid with the molecular formula c16h17brcln3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l31mm1385e, chemically known as 4(3h)-quinazolinone, 7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, trans- but generally known as halofuginone, which bears us nih compound identifier 62891. european medicines agency schedules halofuginone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08000mig. the term halofuginone is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). halofuginone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule halofuginone under hs 29335995 and sitc 51576. as of q4 2014, halofuginone remains the us fda preferred term for this commodity. halofuginone bears us nlm identifiers umls id c0062095 and nci concept code c1120. smiles: brc1cc2ncn(cc(=o)cc3ncccc3o)c(=o)c2cc1cl.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. imidocarb. this classification denotes an antiprotozoal agent with the molecular formula c19h20n6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8uss3k0vdh, chemically known as 3,3-di-2-imidazolin-2-ylcarbanilide dihydrochloride but generally known as imidocarb, which bears us nih compound identifier 21389. european medicines agency schedules imidocarb in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08146mig. the term imidocarb is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). imidocarb is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule imidocarb under hs 29332990 and sitc 51573. as of q4 2014, imidocarb remains the us fda preferred term for this commodity. imidocarb bears us nlm identifiers umls id c0020928 and nci concept code c83790. smiles: o=c(nc1cc(c2=nccn2)ccc1)nc1cc(c2=nccn2)ccc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. ipronidazole. this classification denotes an antiprotozoal agent with the molecular formula c7h11n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 045bu63e23, chemically known as 1h-imidazole, 2-isopropyl-1-methyl-5-nitro- but generally known as ipronidazole, which bears us nih compound identifier 26951. european medicines agency schedules ipronidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08284mig. the term ipronidazole is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). ipronidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ipronidazole under hs 29332990 and sitc 51573. as of q4 2014, ipronidazole remains the us fda preferred term for this commodity. ipronidazole bears us nlm identifiers umls id c0022060 and nci concept code c76423. smiles: o[n](=o)c1n(c(nc1)c(c)c)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. melarsomine. this classification denotes an antihelminthic agent with the molecular formula c13h21asn8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 374gj0s41a, chemically known as bis(2-aminoethyl) p-((4,6-diamino-s-triazin-2-yl)amino)dithiobenzenearsonite but generally known as melarsomine, which bears us nih compound identifier 65962. european medicines agency schedules melarsomine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08719mig. the term melarsomine is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). most nations schedule melarsomine under hs 29336980 and sitc 51576. as of q4 2014, melarsomine remains the us fda preferred term for this commodity. melarsomine bears us nlm identifiers umls id c0171462 and nci concept code c66078. smiles: [as](sccn)(sccn)c1ccc(nc2nc(nc(n2)n)n)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. moxnidazole. this classification denotes an antiprotozoal agent with the molecular formula c13h18n6o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9j21260bcq, chemically known as 2-oxazolidinone, 3-(((1-methyl-5-nitro-1h-imidazol-2-yl)methylene)amino)-5-(4-morpholinylmethyl)- but generally known as moxnidazole, which bears us nih compound identifier 9571039. european medicines agency schedules moxnidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09091mig. the term moxnidazole is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). moxnidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule moxnidazole under hs 29349990 and sitc 51579. as of q4 2014, moxnidazole remains the us fda preferred term for this commodity. moxnidazole bears us nlm identifiers umls id c0066836 and nci concept code c90756. smiles: o1c(cn2ccocc2)cn(/n=c/c2n(c([n](=o)o)cn2)c)c1=o.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. mepacrine or quinacrine. this classification denotes an antiprotozoal agent with the molecular formula c23h30cln3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h0c805xyde, chemically known as 1,4-pentanediamine, n4- (6-chloro-2-methoxy-9-acridinyl)-n1,n1-diethyl-, dihydrochloride but generally known as mepacrine, which bears us nih compound identifier 237. european medicines agency schedules mepacrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08744mig. the term mepacrine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules mepacrine in its anatomical therapeutic chemical (atc) classification. mepacrine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. mepacrine or quinacrine bears us nlm identifiers umls id c0034403 and nci concept code c87656. smiles: clc1cc2nc3c(c(nc(cccn(cc)cc)c)c2cc1)cc(oc)cc3.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. miltefosine. this classification denotes an alkylphosphocholine compound with the molecular formula c21h46no4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 53ey29w7ec, chemically known as 3,5-dioxa-4-phosphaunacosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-, hydroxide, inner salt, 4-oxide but generally known as miltefosine, which bears us nih compound identifier 3599. european medicines agency schedules miltefosine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08969mig. the term miltefosine is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules miltefosine in its anatomical therapeutic chemical (atc) classification. miltefosine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule miltefosine under hs 29239000 and sitc 51481. as of q4 2014, miltefosine remains the us fda preferred term for this commodity. miltefosine bears us nlm identifiers umls id c0068006 and nci concept code c1170. smiles: p(=o)(occ[n](c)(c)c)(occcccccccccccccc)o.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. monensin. this classification denotes an antiprotozoal agent with the molecular formula c36h62o11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 906o0yj6zp, chemically known as monensin, monosodium salt but generally known as monensin, which bears us nih compound identifier 4243. european medicines agency schedules monensin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09048mig. the term monensin is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). most nations schedule monensin under hs 29419000 and sitc 54139. as of q4 2014, monensin remains the us fda preferred term for this commodity. monensin bears us nlm identifiers umls id c0026408 and nci concept code c83971. smiles: o1c(c2oc(cc2c)c2oc(o)(c(cc2c)c)co)(ccc1c1(oc2(oc(c(c(o)c2)c)c(c(oc)c(c)c(=o)o)c)cc1)c)cc.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. moxidectin. this classification denotes an antiparasitic agent with the molecular formula c37h53no8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ngu5h31yo9, chemically known as milbemycin b, 5-o-demethyl-28-deoxy-25-((1e)-1,3-dimethyl-1-butenyl)-6,28-epoxy-23-(methoxyimino)-, (6r,23e,25s)- but generally known as moxidectin, which bears us nih compound identifier 9571036. european medicines agency schedules moxidectin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09085mig. the term moxidectin is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). moxidectin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, moxidectin remains the us fda preferred term for this commodity. moxidectin bears us nlm identifiers umls id c0163557 and nci concept code c73264. smiles: o1c2(oc(c(c(=n\\oc)\\c2)c)/c(=c/c(c)c)c)cc2oc(=o)c3c4(o)c(occ4=cc=cc(cc(=ccc1c2)c)c)c(o)c(=c3)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. phanquinone or phanquone. this classification denotes a topical anti-infective agent and antiprotozoal agent with the molecular formula c12h6n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier id94is6n8j, chemically known as 4,7-phenanthroline-5,6-quinone but generally known as phanquinone, which bears us nih compound identifier 6764. european medicines agency schedules phanquinone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09742mig. the term phanquinone is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules phanquinone in its anatomical therapeutic chemical (atc) classification. phanquinone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. phanquinone or phanquone bears us nlm identifiers umls id c0070517 and nci concept code c90620. smiles: c1=cc2=c(c(=o)c(=o)c3=c2c=cc=n3)n=c1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. nemadectin. this classification denotes an antiparasitic agent with the molecular formula c36h52o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1y8vj1g3ty, chemically known as milbemycin b, 5-o-demethyl-28-deoxy-25-(1,3-dimethyl-1-butenyl)-6,28-epoxy-23-hydroxy-, (6r,23s,25s(e))- but generally known as nemadectin, which bears us nih compound identifier 6436124. european medicines agency schedules nemadectin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09189mig. the term nemadectin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). nemadectin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nemadectin under hs 29419000 and sitc 54139. as of q4 2014, nemadectin remains the us fda preferred term for this commodity. nemadectin bears us nlm identifiers umls id c0068494 and nci concept code c90750. smiles: o1c2(oc3cc(oc(=o)c4c5(o)c(occ5=cc=cc(cc(=cc3)c)c)c(o)c(=c4)c)c2)cc(o)c(c1/c(=c/c(c)c)c)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. nifurtimox. this classification denotes an antiprotozoal agent with the molecular formula c10h13n3o5s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier m84i3k7c2o, chemically known as 4-thiomorpholinamine, 3-methyl-n-((5-nitro-2-furanyl)methylene)-, 1,1-dioxide but more generally known as nifurtimox, which bears u.s. national institutes of health compound identifier 6842999. the european medicines agency schedules nifurtimox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09280mig. the term nifurtimox is an international non-proprietary name or inn (see world health organization inn reference publication, volume 23, no. 10 1969, list 9). the world health organization schedules nifurtimox in its anatomical therapeutic chemical (atc) classification. nifurtimox is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1cs(=o)(=o)ccn1/n=c/c2=cc=c(o2)[n+](=o)[o-].. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. nitarsone. this classification denotes an antiprotozoal agent with the molecular formula c6h6asno5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jp2en8woru, chemically known as benzenearsonic acid, p-nitro- but generally known as nitarsone, which bears us nih compound identifier 66826. european medicines agency schedules nitarsone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09310mig. the term nitarsone is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). nitarsone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, nitarsone remains the us fda preferred term for this commodity. nitarsone bears us nlm identifiers umls id c0068787 and nci concept code c76426. smiles: [as](=o)(o)(o)c1ccc([n](=o)o)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. ontianil. this classification denotes an antihelminthic agent with the molecular formula c13h12clno2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cwd6r2j64d, chemically known as 2,6-dioxocyclohexanethiocarboxylic acid 4-chloroanilide but generally known as ontianil, which bears us nih compound identifier 3033959. european medicines agency schedules ontianil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09447mig. the term ontianil is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). ontianil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ontianil under hs 29309085 and sitc 51549. as of q4 2014, ontianil remains the us fda preferred term for this commodity. ontianil bears us nlm identifiers umls id c2983855 and nci concept code c90729. smiles: clc1ccc(nc(=s)c2c(=o)cccc2=o)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. parvaquone. this classification denotes an antimalarial agent with the molecular formula c16h16o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a2bh18685w, chemically known as 1,4-naphthalenedione, 2-cyclohexyl-3-hydroxy- but generally known as parvaquone, which bears us nih compound identifier 71825. european medicines agency schedules parvaquone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09634mig. the term parvaquone is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). parvaquone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule parvaquone under hs 29146990 and sitc 51629. as of q4 2014, parvaquone remains the us fda preferred term for this commodity. parvaquone bears us nlm identifiers umls id c0070129 and nci concept code c66327. smiles: oc1=c(c2ccccc2)c(=o)c(=o)c2c1cccc2.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. sodium stibogluconate. this classification denotes an enzyme inhibitor and antiparasitic agent with the molecular formula c12h18o17sb2.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v083s0159d, chemically known as trinatrium bis(gluconato(3)-o2,o3,o4)hydroxooxido-oxy-bis-antimonat(v) but generally known as sodium stibogluconate, which bears us nih compound identifier 16683012. european medicines agency schedules sodium stibogluconate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04492mig. world health organization schedules sodium stibogluconate in its anatomical therapeutic chemical (atc) classification. most nations schedule sodium stibogluconate under hs 29420000 and sitc 51699. as of q4 2014, sodium stibogluconate remains the us fda preferred term for this commodity. sodium stibogluconate bears us nlm identifiers umls id c0030895 and nci concept code c61083. smiles: c([c@h]([c@@h]1[c@@h]([c@@h](o[sb](=o)(o1)o[sb]2(=o)o[c@@h]([c@@h]([c@@h](o2)c(=o)[o-])o)[c@@h](co)o)c(=o)[o-])o)o)o.[na+].[na+].. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. ponazuril. this classification denotes an antiprotozoal agent with the molecular formula c18h14f3n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jpw84as66u, chemically known as 1-methyl-3-(4-(p-((trifluoromethyl)sulfonyl)phenoxy)-m-tolyl)-s-triazine-2,4,6(1h,3h,5h)-trione. but generally known as ponazuril, which bears us nih compound identifier 3050408. the term ponazuril is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). most nations schedule ponazuril under hs 29336980 and sitc 51576. as of q4 2014, ponazuril remains the us fda preferred term for this commodity. ponazuril bears us nlm identifiers umls id c0961649 and nci concept code c72600. smiles: cc1=c(c=cc(=c1)n2c(=o)nc(=o)n(c2=o)c)oc3=cc=c(c=c3)s(=o)(=o)c(f)(f)f.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. pretamazium iodide. this classification denotes an antihelminthic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7z32z641h2. european medicines agency schedules pretamazium iodide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10031mig. pretamazium iodide generally arises in the molecular formula c29h29n2s.i. the term pretamazium iodide is an international non-proprietary name or inn. most nations schedule pretamazium iodide under hs 29341000 and sitc 51579. as of q4 2014, pretamazium iodide remains the us fda preferred term for this commodity. pretamazium iodide bears us nlm identifiers umls id c2347671 and nci concept code c74150. smiles: i.s1c([n](c(c2ccc(cc2)c2ccccc2)c1)cc)/c=c/c1ccc(n2cccc2)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. quinfamide. this classification denotes an antiprotozoal agent with the molecular formula c16h13cl2no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o1zb1046r1, chemically known as 2-furoic acid ester with 1-(dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol but generally known as quinfamide, which bears us nih compound identifier 71743. european medicines agency schedules quinfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10215mig. the term quinfamide is an international non-proprietary name. quinfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule quinfamide under hs 29349990 and sitc 51579. as of q4 2014, quinfamide remains the us fda preferred term for this commodity. quinfamide bears us nlm identifiers umls id c0072865 and nci concept code c72156. smiles: clc(cl)c(=o)n1cccc2c1ccc(oc(=o)c1occc1)c2.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. robenidine. this classification denotes an antiprotozoal agent with the molecular formula c15h13cl2n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4888me6c4e, chemically known as 1,3-bis((p-chlorobenzylidene)amino)guanidine but generally known as robenidine, which bears us nih compound identifier 9570438. european medicines agency schedules robenidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10348mig. the term robenidine is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). robenidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule robenidine under hs 29280090 and sitc 51486. as of q4 2014, robenidine remains the us fda preferred term for this commodity. robenidine bears us nlm identifiers umls id c0035780 and nci concept code c76427. smiles: clc1ccc(cc1)/c=n/n/c(=n/n=c/c1ccc(cl)cc1)n.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. satranidazole. this classification denotes an antiprotozoal agent with the molecular formula c8h11n5o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4n7g8a6439, chemically known as 2-imidazolidinone, 1-(1-methyl-5-nitro-1h-imidazol-2-yl)-3-(methylsulfonyl)- but generally known as satranidazole, which bears us nih compound identifier 41841. european medicines agency schedules satranidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10459mig. the term satranidazole is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). satranidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule satranidazole under hs 29350090 and sitc 51580. as of q4 2014, satranidazole remains the us fda preferred term for this commodity. satranidazole bears us nlm identifiers umls id c0141597 and nci concept code c72155. smiles: s(=o)(=o)(n1ccn(c1=o)c1n(c([n](=o)o)cn1)c)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. semduramicin. this classification denotes an antiprotozoal agent with the molecular formula c45h76o16, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p6vxl377wl, chemically known as uk 61,689 but generally known as semduramicin, which bears us nih compound identifier 71327. european medicines agency schedules semduramicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10479mig. the term semduramicin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). semduramicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule semduramicin under hs 29419000 and sitc 54139. as of q4 2014, semduramicin remains the us fda preferred term for this commodity. semduramicin bears us nlm identifiers umls id c0141951 and nci concept code c76009. smiles: o1c(c2oc(c3oc(cc3oc3oc(c(oc)cc3)c)c3oc(o)(c(cc3c)c)c)(cc2)c)(ccc21oc(c(c(o)c2)c)c(c1oc(o)(c(c(o)c1oc)c)cc(=o)o)c)c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. spirazine or spirotriazine. this classification denotes an antiparasitic agent with the molecular formula c15h20cln5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wv516juv0b, chemically known as 1,3,5-triazaspiro(5.5)undeca-1,3-diene, 2,4-diamino-5-(p-chlorophenyl)-9-methyl- but generally known as spirazine, which bears us nih compound identifier 210321. european medicines agency schedules spirazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10622mig. the term spirazine is an international non-proprietary name. spirazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. spirazine or spirotriazine bears us nlm identifiers umls id c2827337 and nci concept code c84180. smiles: clc1ccc(n2c3(n=c(n=c2n)n)ccc(cc3)c)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. sulazuril. this classification denotes an antiprotozoal agent and antihelminthic with the molecular formula c17h15cl2n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2136b7t7ke, chemically known as 2-(3,5-dichloro-4-(p-(methylsulfonyl)phenoxy)phenyl)dihydro-1-methyl-as-triazine-3,5(2h,4h)-dione but generally known as sulazuril, which bears us nih compound identifier 65904. european medicines agency schedules sulazuril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10675mig. the term sulazuril is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). sulazuril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulazuril under hs 29336980 and sitc 51576. as of q4 2014, sulazuril remains the us fda preferred term for this commodity. sulazuril bears us nlm identifiers umls id c2348592 and nci concept code c72602. smiles: clc1cc(n2n(cc(=o)nc2=o)c)cc(cl)c1oc1ccc(s(=o)(=o)c)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. sulfaclozine or sulfachlorpyridazine. this classification denotes an antiprotozoal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 69yp7z48cw. european medicines agency schedules sulfaclozine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10693mig. sulfaclozine generally arises in the molecular formula c10h9cln4o2s. the term sulfaclozine is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11.) sulfaclozine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. sulfaclozine or sulfachlorpyridazine bears us nlm identifiers umls id c0038672 and nci concept code c76974. smiles: c1=cc(=cc=c1n)s(=o)(=o)nc2=cn=cc(=n2)cl.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. sulnidazole. this classification denotes an antiprotozoal agent with the molecular formula c9h14n4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 504lr309yv, chemically known as r 26,412 but generally known as sulnidazole, which bears us nih compound identifier 3037172. european medicines agency schedules sulnidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10750mig. the term sulnidazole is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). sulnidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulnidazole under hs 29332990 and sitc 51573. as of q4 2014, sulnidazole remains the us fda preferred term for this commodity. sulnidazole bears us nlm identifiers umls id c2348602 and nci concept code c73278. smiles: s=c(oc)nccn1c(ncc1[n](=o)o)cc.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. suramin. this classification denotes an angiogenesis activator inhibitor with the molecular formula c51h40n6o23s6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6032d45bem, chemically known as 1,3,5-naphthylenetrisulfonic acid, 8,8-(ureylenebis(m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino))di- but generally known as suramin, which bears us nih compound identifier 5361. european medicines agency schedules suramin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04651mig. suramin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, suramin remains the us fda preferred term for this commodity. suramin bears us nlm identifiers umls id c0038880 and nci concept code c853. smiles: s(=o)(=o)(o)c1c2c(c(s(=o)(=o)o)ccc2nc(=o)c2cc(nc(=o)c3cc(nc(=o)nc4cc(c(=o)nc5cc(c(=o)nc6c7c(c(s(=o)(=o)o)cc6)cc(s(=o)(=o)o)cc7s(=o)(=o)o)ccc5c)ccc4)ccc3)c(cc2)c)cc(s(=o)(=o)o)c1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. symetine. this classification denotes an antiprotozoal agent with the molecular formula c30h48n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uz8wty8051, chemically known as 4,4-(ethylenedioxy(bis(n-hexyl-n-methylbenzylamine) but generally known as symetine, which bears us nih compound identifier 214341. european medicines agency schedules symetine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10791mig. the term symetine is an international non-proprietary name. symetine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule symetine under hs 29222900 and sitc 51462. as of q4 2014, symetine remains the us fda preferred term for this commodity. symetine bears us nlm identifiers umls id c2699743 and nci concept code c76431. smiles: o(c1ccc(cn(cccccc)c)cc1)ccoc1ccc(cn(cccccc)c)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. teclozan. this classification denotes a benzylamine and acetamide with the molecular formula c20h28cl4n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k9rif0coub, chemically known as 2,2-dichloro-n-(4-(((dichloroacetyl)(2-ethoxyethyl)amino)methyl)benzyl)-n-(2-ethoxyethyl)acetamide but generally known as teclozan, which bears us nih compound identifier 21723. european medicines agency schedules teclozan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10863mig. world health organization schedules teclozan in its anatomical therapeutic chemical (atc) classification. teclozan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule teclozan under hs 29242995 and sitc 51479. as of q4 2014, teclozan remains the us fda preferred term for this commodity. smiles: clc(cl)c(=o)n(cc1ccc(cn(ccocc)c(=o)c(cl)cl)cc1)ccocc.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. tenonitrozole. this classification denotes an anti-protozoal with the molecular formula c8h5n3o3s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pbq7wle1wp, chemically known as n-(5-nitro-1,3-thiazol-2-yl)thiophene-2-carboxamide but generally known as tenonitrozole, which bears us nih compound identifier 19646. european medicines agency schedules tenonitrozole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10897mig. most nations schedule tenonitrozole under hs 29341000 and sitc 51579. as of q4 2014, tenonitrozole remains the us fda preferred term for this commodity. smiles: c1=csc(=c1)c(=o)nc2=nc=c(s2)[n+](=o)[o-].. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. tivanidazole. this classification denotes an antiprotozoal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7e136tjt00. european medicines agency schedules tivanidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11123mig. tivanidazole generally arises in the molecular formula c11h13n5o2s. the term tivanidazole is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23.) tivanidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tivanidazole under hs 29349990 and sitc 51579. as of q4 2014, tivanidazole remains the us fda preferred term for this commodity. tivanidazole bears us nlm identifiers umls id c2348794 and nci concept code c73279. smiles: ccc1=nn=c(s1)/c(=c/c2=nc=c(n2c)[n+](=o)[o-])/c.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. toltrazuril. this classification denotes an antiprotozoal agent with the molecular formula c18h14f3n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qvz3iar3js, chemically known as 1,3,5-triazine-2,4,6(1h,3h,5h)-trione, 1-methyl-3-(3-methyl-4-(4-((trifluoromethyl)thio)phenoxy)phenyl)- but generally known as toltrazuril, which bears us nih compound identifier 68591. european medicines agency schedules toltrazuril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11181mig. the term toltrazuril is an international non-proprietary name. toltrazuril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule toltrazuril under hs 29336980 and sitc 51576. as of q4 2014, toltrazuril remains the us fda preferred term for this commodity. toltrazuril bears us nlm identifiers umls id c0146196 and nci concept code c72601. smiles: s(c1ccc(oc2c(cc(n3c(=o)n(c(=o)[nh]c3=o)c)cc2)c)cc1)c(f)(f)f.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. tosulur. this classification denotes an antiprotozoal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i04mf82gw9. european medicines agency schedules tosulur in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11202mig. tosulur generally arises in the molecular formula c11h15no5s. the term tosulur is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) tosulur is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tosulur under hs 29350090 and sitc 51580. as of q4 2014, tosulur remains the us fda preferred term for this commodity. tosulur bears us nlm identifiers umls id c2699972 and nci concept code c76434. smiles: cc1=cc=c(c=c1)s(=o)(=o)nc(=o)occoc.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. troquidazole. this classification denotes an antiprotozoal agent with the molecular formula c14h15n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 41x4for202, chemically known as 4-morpholinecarboximidamide, n-(3-nitro-4-quinolinyl)- but generally known as troquidazole, which bears us nih compound identifier 65903. european medicines agency schedules troquidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11347mig. the term troquidazole is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). most nations schedule troquidazole under hs 29349990 and sitc 51579. as of q4 2014, troquidazole remains the us fda preferred term for this commodity. troquidazole bears us nlm identifiers umls id c2700085 and nci concept code c76435. smiles: o1ccn(cc1)/c(=n/c1c2c(ncc1[n](=o)o)cccc2)n.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. aminosalicylate sodium or sodium aminosalicylate. this classification denotes an antitubercular agent with the molecular formula c7h6no3.na.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s38b9w6axw, chemically known as 4-amino,2-hydroxy-benzoic acid but more generally known as aminosalicylate sodium, which bears u.s. national institutes of health compound identifier 4649. european medicines agency schedules aminosalicylate sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12861mig. world health organization schedules aminosalicylate sodium in its anatomical therapeutic chemical (atc) classification. as of q4 2014, aminosalicylate sodium remains us fdas preferred term for this commodity. aminosalicylate sodium bears us nlm identifiers umls id c0301336 and nci concept code c47958. most nations, for tariff and trade purposes, schedule aminosalicylate sodium under hs 29225010 and sitc 51467. smiles: c1cc(c(cc1n)o)c(=o)[o-].[na+].. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. bidimazium iodide. this classification denotes an antihelminthic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2d4432zp6m. european medicines agency schedules bidimazium iodide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05823mig. bidimazium iodide generally arises in the molecular formula c26h25n2s.i. the term bidimazium iodide is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12.) most nations schedule bidimazium iodide under hs 29341000 and sitc 51579. as of q4 2014, bidimazium iodide remains the us fda preferred term for this commodity. bidimazium iodide bears us nlm identifiers umls id c2825733 and nci concept code c81724. smiles: i.s1c([n](c(c2ccc(cc2)c2ccccc2)c1)c)/c=c\\c1ccc(n(c)c)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. acetarsol or acetarsone. this classification denotes an antihelminthic agent with the molecular formula c8h10asno5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 806529yu1n, chemically known as m-arsanilic acid, n-acetyl-4-hydroxy- but generally known as acetarsol, which bears us nih compound identifier 1985. acetarsol comes in many forms, including base, diethylaminsalz, natrium, and sodium. european medicines agency schedules acetarsol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05218mig. the term acetarsol is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules acetarsol in its anatomical therapeutic chemical (atc) classification. acetarsol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. acetarsol or acetarsone bears us nlm identifiers umls id c0050436 and nci concept code c61621. smiles: [as](=o)(o)(o)c1cc(nc(=o)c)c(o)cc1.. "
"amebicides and trichomonacides. this classification denotes drugs that destroy amebae or protozoans, parasitic organisms, and species thereof which cause amebiasis in man and animal. amebae are organisms that evince a vesicular nucleus and formation of several lodopodia, one of which is dominant at a given time, and which reproduce asexually by binary fission. such organsms give rise to afflictions such as acanthamoeba keratitis, blastocystis, amebic dysentery, entamoebiasis, and amebic liver abscess, or cause central nervous system parasitic infections, helminthiasis, mesomycetozoea infections, and parasitemia. common conditions that this classifications drugs treat include anisakiasis, balantidiasis, cryptosporidiosis, dientamoebiasis, entamoebiasis, fascioliasis, giardiasis, hepatic echinococcosis, and rhinosporidiosis. these drugs, known as amebicides, antiprotozoals, and trichomonacides, typically target a) a genus of coccidian parasites of the family cryptosporidiidae, found in the intestinal epithelium of many vertebrates including humans,known as cryptosporidium; and b) an order of parasitic eukaryotes typically having four to six flagella, know as trichomonadida.. pentamidine isethionate. this classification denotes an antiprotozoal agent and antifungal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v2p3k60da2. european medicines agency schedules pentamidine diisetionate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12202mig. pentamidine isethionate generally arises in the molecular formula c19h24n4o2.2c2h6o4s. the term pentamidine isethionate is a european pharmacopoeia designation. most nations schedule pentamidine isethionate under hs 29252900 and sitc 51482. as of q4 2014, pentamidine isethionate remains the us fda preferred term for this commodity. pentamidine isethionate bears us nlm identifiers umls id c0591959 and nci concept code c29349. smiles: c1cc(ccc1c(=n)n)occcccoc2ccc(cc2)c(=n)n.c(cs(=o)(=o)o)o.c(cs(=o)(=o)o)o.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. . "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. mefloquine. this classification denotes an antimalarial agent with the molecular formula c17h16f6n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tml814419r, chemically known as 4-quinolinemethanol, .alpha.-2-piperidinyl-2,8-bis(trifluoromethyl)-, (r*,s*)-(.+/-.)- but generally known as mefloquine, which bears us nih compound identifier 4046. european medicines agency schedules mefloquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08709mig. the term mefloquine is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules mefloquine in its anatomical therapeutic chemical (atc) classification. mefloquine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mefloquine under hs 29334990 and sitc 51575. as of q4 2014, mefloquine remains the us fda preferred term for this commodity. mefloquine bears us nlm identifiers umls id c0025153 and nci concept code c61827. smiles: fc(f)(f)c1nc2c(c(c(o)c3ncccc3)c1)cccc2c(f)(f)f.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. primaquine. this classification denotes an antimalarial agent with the molecular formula c15h21n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mvr3634gx1, chemically known as 1,4-pentanediamine, n4-(6-methoxy-8-quinolinyl)- (9ci) but generally known as primaquine, which bears us nih compound identifier 4908. european medicines agency schedules primaquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10043mig. the term primaquine is an international non-proprietary name. world health organization schedules primaquine in its anatomical therapeutic chemical (atc) classification. primaquine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule primaquine under hs 29334990 and sitc 51575. as of q4 2014, primaquine remains the us fda preferred term for this commodity. primaquine bears us nlm identifiers umls id c0033126 and nci concept code c62071. smiles: o(c1cc(nc(cccn)c)c2ncccc2c1)c.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. quinine. this classification denotes an antimalarial agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a7v27phc7a. european medicines agency schedules quinine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15084mig. quinine generally arises in the molecular formula c20h24n2o2. the term quinine is a united states homeopathic pharmacopoeia name designation. most nations schedule quinine under hs 29392000 and sitc 54142. as of q4 2014, quinine remains the us fda preferred term for this commodity. quinine bears us nlm identifiers umls id c0034417 and nci concept code c794. smiles: oc(c1n2cc(c(c1)cc2)c=c)c1c2c(ncc1)ccc(oc)c2.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. chloroquine. this classification denotes an antimalarial agent with the molecular formula c18h26cln3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 886u3h6uff, chemically known as 1,4-pentanediamine, n(sup 4)-(7-chloro-4-quinolinyl)-n(sup 1),n(sup 1)-diethyl- but generally known as chloroquine, which bears us nih compound identifier 2719. european medicines agency schedules chloroquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06196mig. the term chloroquine is an international non-proprietary name. world health organization schedules chloroquine in its anatomical therapeutic chemical (atc) classification. chloroquine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule chloroquine under hs 29334990 and sitc 51575. as of q4 2014, chloroquine remains the us fda preferred term for this commodity. chloroquine bears us nlm identifiers umls id c0008269 and nci concept code c61671. smiles: clc1cc2nccc(nc(cccn(cc)cc)c)c2cc1.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. proguanil. this classification denotes a dihydrofolate reductase inhibitor and antimalarial agent with the molecular formula c11h16cln5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s61k3p7b2v, chemically known as sn 12,837 but generally known as chlorguanide, which bears us nih compound identifier 6178111. european medicines agency schedules proguanil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10079mig. the term proguanil is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules chlorguanide in its anatomical therapeutic chemical (atc) classification. most nations schedule proguanil under hs 29252900 and sitc 51482. as of q4 2014, proguanil remains the us fda preferred term for this commodity. proguanil bears us nlm identifiers umls id c0008241 and nci concept code c61907. smiles: cc(c)n=c(n)/n=c(\\n)/nc1=cc=c(c=c1)cl.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. pyrimethamine. this classification denotes a dihydrofolate reductase inhibitor and antimalarial agent with the molecular formula c12h13cln4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z3614qox8w, chemically known as 2,4-pyrimidinediamine, 5-(p-chlorophenyl)-6-ethyl- but generally known as pyrimethamine, which bears us nih compound identifier 4993. european medicines agency schedules pyrimethamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10169mig. the term pyrimethamine is an international non-proprietary name. world health organization schedules pyrimethamine in its anatomical therapeutic chemical (atc) classification. pyrimethamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pyrimethamine under hs 29335995 and sitc 51576. as of q4 2014, pyrimethamine remains the us fda preferred term for this commodity. pyrimethamine bears us nlm identifiers umls id c0034283 and nci concept code c788. smiles: ccc1=c(c(=nc(=n1)n)n)c2=cc=c(c=c2)cl.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. artemether. this classification denotes an antimalarial agent with the molecular formula c16h26o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c7d6t3h22j, chemically known as 3,12-epoxy-12h-pyrano(4,3-j)-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-trimethyl-, (3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12ar)-, (+)- but generally known as artemether, which bears us nih compound identifier 68911. european medicines agency schedules artemether in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05574mig. the term artemether is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules artemether in its anatomical therapeutic chemical (atc) classification. artemether is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule artemether under hs 29329970 and sitc 51569. as of q4 2014, artemether remains the us fda preferred term for this commodity. artemether bears us nlm identifiers umls id c0052429 and nci concept code c73001. smiles: o1oc2(oc3oc(oc)c(c4c13c(c(cc4)c)cc2)c)c.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. halofantrine. this classification denotes an antimalarial agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q2os4303hz. european medicines agency schedules halofantrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07998mig. halofantrine generally arises in the molecular formula c26h30cl2f3no. the term halofantrine is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20.) halofantrine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule halofantrine under hs 29221980 and sitc 51461. as of q4 2014, halofantrine remains the us fda preferred term for this commodity. halofantrine bears us nlm identifiers umls id c0120726 and nci concept code c65838. smiles: clc1c2cc(c(o)ccn(cccc)cccc)c3c(c2cc(cl)c1)cc(cc3)c(f)(f)f.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. hydroxychloroquine. this classification denotes an antimalarial agent with the molecular formula c18h26cln3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4qwg6n8qkh, chemically known as ethanol, 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)- but generally known as hydroxychloroquine, which bears us nih compound identifier 3652. european medicines agency schedules hydroxychloroquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08077mig. the term hydroxychloroquine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules hydroxychloroquine in its anatomical therapeutic chemical (atc) classification. hydroxychloroquine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule hydroxychloroquine under hs 29334990 and sitc 51575. as of q4 2014, hydroxychloroquine remains the us fda preferred term for this commodity. hydroxychloroquine bears us nlm identifiers umls id c0020336 and nci concept code c557. smiles: clc1cc2nccc(nc(cccn(cco)cc)c)c2cc1.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. amodiaquine. this classification denotes an antimalarial agent with the molecular formula c20h22cln3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 220236ed28, chemically known as 6398-98-7(dihydrochloride, dihydrate) but generally known as amodiaquin, which bears us nih compound identifier 2165. amodiaquin most often arises in simple, dihydrochloride, and dihyrdate forms. european medicines agency schedules amodiaquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05470mig. the term amodiaquine is an international non-proprietary name. world health organization schedules amodiaquin in its anatomical therapeutic chemical (atc) classification. most nations schedule amodiaquine under hs 29334990 and sitc 51575. as of q4 2014, amodiaquine remains the us fda preferred term for this commodity. amodiaquine bears us nlm identifiers umls id c0002641 and nci concept code c65231. smiles: ccn(cc)cc1=c(c=cc(=c1)nc2=c3c=cc(=cc3=nc=c2)cl)o.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. artesunate. this classification denotes an antiprotozoal agent with the molecular formula c19h28o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 60w3249t9m, chemically known as 4-oxo-4-(((3r,5as,6r,8as,9r,10s,12r,12ar)-3,6,9-trimethyldecahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10-yl hydrogen butanedioate but generally known as artesunate, which bears us nih compound identifier 65664. european medicines agency schedules artesunate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05576mig. the term artesunate is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 1, 2006, list 55). world health organization schedules artesunate in its anatomical therapeutic chemical (atc) classification. artesunate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule artesunate under hs 29329970 and sitc 51569. as of q4 2014, artesunate remains the us fda preferred term for this commodity. artesunate bears us nlm identifiers umls id c0052432 and nci concept code c73005. smiles: o1oc2(oc3oc(oc(=o)ccc(=o)o)c(c4c13c(c(cc4)c)cc2)c)c.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. benflumetol or lumefantrine. this classification denotes an antimalarial agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f38r0jr742. european medicines agency schedules lumefantrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08618mig. lumefantrine generally arises in the molecular formula c30h32cl3no. the term lumefantrine is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 1 1998, list 39.) lumefantrine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. benflumetol or lumefantrine bears us nlm identifiers umls id c0531104 and nci concept code c81541. smiles: clc1cc(c(o)cn(cccc)cccc)c2c(/c(=c/c3ccc(cl)cc3)c3c2ccc(cl)c3)c1.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. amopyroquine. this classification denotes an antimalarial agent with the molecular formula c20h20cln3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sv6l22y9qf, chemically known as 4-((7-chloro-4-quinolyl)amino)-alpha-1-pyrrolidinyl-o-cresol or 4-[(7-chloranylquinolin-4-yl)amino]-2-(pyrrolidin-1-ylmethyl)phenol, but generally known as amopyroquine, which bears us nih compound identifier 25194. european medicines agency schedules amopyroquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05475mig. most nations schedule amopyroquine under hs 29334990 and sitc 51575. as of q4 2014, amopyroquine remains the us fda preferred term for this commodity. amopyroquine bears us nlm identifiers umls id c0051735 and nci concept code c73000. smiles: c1ccn(c1)cc2=c(c=cc(=c2)nc3=c4c=cc(=cc4=nc=c3)cl)o.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. amquinate. this classification denotes an antiprotozoal agent with the molecular formula c18h24n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 21n28z70ci, chemically known as 3-quinolinecarboxylic acid, 7-(diethylamino)-4-hydroxy-6-propyl-, methyl ester but generally known as amquinate, which bears us nih compound identifier 28414. european medicines agency schedules amquinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05492mig. the term amquinate is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). amquinate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amquinate under hs 29334910 and sitc 51575. as of q4 2014, amquinate remains the us fda preferred term for this commodity. amquinate bears us nlm identifiers umls id c0601306 and nci concept code c90754. smiles: o=c1c2c([nh]cc1c(=o)oc)cc(n(cc)cc)c(ccc)c2.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. artemotil or beta-arteether. this classification denotes an antimalarial agent with the molecular formula c17h28o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xgl7gfb9yi, chemically known as 3,12-epoxy-12h-pyrano(4,3-j)-1,2-benzodioxepin, decahydro-10-ethoxy-3,6,9-trimethyl-, (3r-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12ar*))- but generally known as arteether, which bears us nih compound identifier 72416. european medicines agency schedules artemotil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00596mig. the term artemotil is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules arteether in its anatomical therapeutic chemical (atc) classification. artemotil or beta-arteether bears us nlm identifiers umls id c0052427 and nci concept code c73002. smiles: ccoc1c(c2ccc(c3c24c(o1)oc(cc3)(oo4)c)c)c.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. arteflene. this classification denotes an antimalarial agent with the molecular formula c19h18f6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5pe5hv9nf0, chemically known as 2,3-dioxabicyclo(3.3.1)nonan-7-one, 4-(2-(2,4-bis(trifluoromethyl)phenyl)ethenyl)-4,8-dimethyl-(1s-(1alpha,4beta(z),5alpha,8beta))- but generally known as arteflene, which bears us nih compound identifier 6436134. european medicines agency schedules arteflene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05573mig. the term arteflene is an international non-proprietary name. most nations schedule arteflene under hs 29329985 and sitc 51569. as of q4 2014, arteflene remains the us fda preferred term for this commodity. arteflene bears us nlm identifiers umls id c0291500 and nci concept code c75263. smiles: fc(f)(f)c1c(/c=c\\c2(ooc3cc2cc(=o)c3c)c)ccc(c1)c(f)(f)f.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. artemisinin. this classification denotes an antiprotozoal agent with the molecular formula c15h22o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9rmu91n5k2, chemically known as 3,12-epoxy-12h-pyranol(4,3-j)-1,2-benzodioxepin-10(3h)-one, octahydro-3,6,9-trimethyl-, (3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12ar*)-(+)- but generally known as artemisinin, which bears us nih compound identifier 68827. artemisinin most often comes in base, type a, and type b forms. european medicines agency schedules artemisinin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05575mig. the term artemisinin is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules artemisinin in its anatomical therapeutic chemical (atc) classification. artemisinin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule artemisinin under hs 29329985 and sitc 51569. as of q4 2014, artemisinin remains the us fda preferred term for this commodity. artemisinin bears us nlm identifiers umls id c0052430 and nci concept code c78093. smiles: o1oc2(oc3oc(=o)c(c4c13c(c(cc4)c)cc2)c)c.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. chlorproguanil. this classification denotes an antiprotozoal agent with the molecular formula c11h15cl2n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8o3249m729, chemically known as 1-(3,4-dichlorophenyl)-5-isopropylbiguanide but generally known as chlorproguanil, which bears us nih compound identifier 9571037. european medicines agency schedules chlorproguanil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06207mig. the term chlorproguanil is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). most nations schedule chlorproguanil under hs 29252900 and sitc 51482. as of q4 2014, chlorproguanil remains the us fda preferred term for this commodity. chlorproguanil bears us nlm identifiers umls id c0055470 and nci concept code c79941. smiles: cc(c)n=c(n)/n=c(\\n)/nc1=cc(=c(c=c1)cl)cl.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. artenimol. this classification denotes an antimalarial agent with the molecular formula c15h24o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6a9o50735x, chemically known as (3r,5as,6r,8as,9r,10s,12r,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano(4,3,-j)-1,2-benzodioxepin-10-ol but generally known as artenimol, which bears us nih compound identifier 179336. european medicines agency schedules artenimol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub30709. the term artenimol is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). world health organization schedules artenimol in its anatomical therapeutic chemical (atc) classification. most nations schedule artenimol under hs 29329985 and sitc 51569. as of q4 2014, artenimol remains the us fda preferred term for this commodity. artenimol bears us nlm identifiers umls id c0058108 and nci concept code c87432. smiles: o1oc2(oc3oc(o)c(c4c13c(c(cc4)c)cc2)c)c.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. atovaquone. this classification denotes an antimalarial and anti-infective agent with the molecular formula c22h19clo3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y883p1z2lt, chemically known as 1,4-naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy- but generally known as atovaquone, which bears us nih compound identifier 74989. atovaquone most often comes in base form and is sometimes combined with proguanil. european medicines agency schedules atovaquone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05602mig. the term atovaquone is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules atovaquone in its anatomical therapeutic chemical (atc) classification. atovaquone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule atovaquone under hs 29147000 and sitc 51629. as of q4 2014, atovaquone remains the us fda preferred term for this commodity. atovaquone bears us nlm identifiers umls id c0165603 and nci concept code c28838. smiles: clc1ccc(c2ccc(cc2)c2=c(o)c3c(c(=o)c2=o)cccc3)cc1.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. bulaquine. this classification denotes an antimalarial agent with the molecular formula c21h27n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tsq6u39q3g, chemically known as 2(3h)-furanone, dihydro-3-(1-((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)ethylidene)- but generally known as bulaquine, which bears us nih compound identifier 3036820. european medicines agency schedules bulaquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00894mig. the term bulaquine is an international non-proprietary name. most nations schedule bulaquine under hs 29349990 and sitc 51579. as of q4 2014, bulaquine remains the us fda preferred term for this commodity. bulaquine bears us nlm identifiers umls id c0082079 and nci concept code c75997. smiles: o1cc/c(=c(\\ncccc(nc2c3ncccc3cc(oc)c2)c)c)c1=o.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. chininum muriaticum. this classification denotes an antimalarial agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 711s8y0t33. european medicines agency schedules quinine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15093mig. quinine hydrochloride generally arises in the molecular formula c20h24n2o2.xclh. the term quinine hydrochloride is a united states homeopathic pharmacopoeia name designation. smiles: cl.oc(c1n2ccc(c1)(cc2)c=c)c1c2c(ncc1)ccc(oc)c2.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. chloroguanide. this classification denotes a dihydrofolate reductase inhibitor and antimalarial agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6t04v14cu9. european medicines agency schedules chloroguanide hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04062mig. chloroguanide hydrochloride generally arises in the molecular formula c11h17cl2n5. the term chloroguanide hydrochloride is a united states adopted name designation. smiles: clc1cc(n(/c(=n/c(c)c)n)c(=n)n)ccc1cl.cl.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. cloquinate. this classification denotes an antiprotozoal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ki24a9ff7s. european medicines agency schedules cloquinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06747mig. cloquinate generally arises in the molecular formula c18h26cln3.2c9h6ino4s. the term cloquinate is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5.) cloquinate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cloquinate under hs 29334990 and sitc 51575. as of q4 2014, cloquinate remains the us fda preferred term for this commodity. cloquinate bears us nlm identifiers umls id c2825690 and nci concept code c81577. smiles: ic1cc(s(=o)(=o)o)c2c(nccc2)c1o.ic1cc(s(=o)(=o)o)c2c(nccc2)c1o.clc1cc2nccc(nc(cccn(cc)cc)c)c2cc1.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. cycloguanil. this classification denotes an antimalarial and folic acid antagonist with the molecular formula c11h14cln5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 26rm326wvn, chemically known as 1-(4-chlorophenyl)-1,6-dihydro-6,6-dimethyl-1,3,5-triazine-2,4-diamine but generally known as cycloguanil, which bears us nih compound identifier 9049. european medicines agency schedules cycloguanil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01526mig. world health organization schedules cycloguanil in its anatomical therapeutic chemical (atc) classification. as of q4 2014, cycloguanil remains the us fda preferred term for this commodity. cycloguanil bears us nlm identifiers umls id c0056751 and nci concept code c81015. smiles: cc1(n=c(n=c(n1c2=cc=c(c=c2)cl)n)n)c.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. docetaxel. this classification denotes a taxane compound and taxane-site binding agent with the molecular formula c43h53no14.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 15h5577cqd, chemically known as docetaxel, anhydrous but generally known as docetaxel, which bears us nih compound identifier 64780. european medicines agency schedules docetaxel in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12492mig. world health organization schedules docetaxel in its anatomical therapeutic chemical (atc) classification. docetaxel is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule docetaxel under hs 29329950 and sitc 51569. as of q4 2014, docetaxel remains the us fda preferred term for this commodity. docetaxel bears us nlm identifiers umls id c0246415 and nci concept code c1526. smiles: o1c2c(oc(=o)c)(c3c(c(o)c2)(c(=o)c(o)c2=c(c(oc(=o)c(o)c(nc(=o)oc(c)(c)c)c4ccccc4)cc(o)(c3oc(=o)c3ccccc3)c2(c)c)c)c)c1.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. enpiroline. this classification denotes an antimalarial agent with the molecular formula c19h18f6n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 8m7y72ep9k chemically known as 4-pyridinemethanol, .alpha.-(2-piperidinyl)-2-(trifluoromethyl)-6-(4-(trifluoromethyl)phenyl)-, (r*,r*)-(+/-)- but generally known as enpiroline, which bears us nih compound identifier 3033333. european medicines agency schedules enpiroline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06545mig. the term enpiroline is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). most nations schedule enpiroline under hs 29333999 and sitc 51574. as of q4 2014, enpiroline remains the us fda preferred term for this commodity. enpiroline bears us nlm identifiers umls id c0059370 and nci concept code c75267. smiles: c1ccnc(c1)c(c2=cc(=nc(=c2)c(f)(f)f)c3=cc=c(c=c3)c(f)(f)f)o.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. quinocide. this classification denotes an antimalarial agent with the molecular formula c15h21n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cng7995y4b, chemically known as 1,4-pentanediamine, n1-(6-methoxy-8-quinolinyl)- (9ci) but generally known as quinocide, which bears us nih compound identifier 68928. european medicines agency schedules quinocide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10219mig. the term quinocide is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). quinocide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule quinocide under hs 29334990 and sitc 51575. as of q4 2014, quinocide remains the us fda preferred term for this commodity. quinocide bears us nlm identifiers umls id c0072873 and nci concept code c73004. smiles: o(c1cc(ncccc(n)c)c2ncccc2c1)c.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. menoctone. this classification denotes an antimalarial agent with the molecular formula c24h32o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qp1a5bd6k9, chemically known as 1,4-naphthoquinone, 2-(8-cyclohexyloctyl)-3-hydroxy- (8ci) but generally known as menoctone, which bears us nih compound identifier 26738. european medicines agency schedules menoctone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08741mig. the term menoctone is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). menoctone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule menoctone under hs 29146990 and sitc 51629. as of q4 2014, menoctone remains the us fda preferred term for this commodity. menoctone bears us nlm identifiers umls id c0065946 and nci concept code c81543. smiles: oc1=c(ccccccccc2ccccc2)c(=o)c(=o)c2c1cccc2.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. mepacrine. this classification denotes an antiprotozoal agent and antineoplastic with the molecular formula c23h30cln3o.2clh.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g6242h2naa, chemically known as 1,4-pentanediamine, n4- (6-chloro-2-methoxy-9-acridinyl)-n1,n1-diethyl-, dihydrochloride but generally known as mepacrine hydrochloride, which bears us nih compound identifier 237. european medicines agency schedules mepacrine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03152mig. most nations schedule mepacrine under hs 29339990 and sitc 51577. smiles: clc1cc2nc3c(c(nc(cccn(cc)cc)c)c2cc1)cc(oc)cc3.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. moxipraquine. this classification denotes an antimalarial agent with the molecular formula c24h38n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gp95seq1aq, chemically known as 1-piperazinepropanol, 4-(6-((6-methoxy-8-quinolyl)amino)hexyl)-alpha-methyl- but generally known as moxipraquine, which bears us nih compound identifier 72091. european medicines agency schedules moxipraquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09088mig. the term moxipraquine is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). moxipraquine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule moxipraquine under hs 29335995 and sitc 51576. as of q4 2014, moxipraquine remains the us fda preferred term for this commodity. moxipraquine bears us nlm identifiers umls id c0611649 and nci concept code c87633. smiles: oc(ccn1ccn(cc1)ccccccnc1c2ncccc2cc(oc)c1)c.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. pamaquine. this classification denotes an antimalarial agent with the molecular formula c19h29n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 99qvl5kpsu, chemically known as 1,4-pentanediamine, n1,n1-diethyl-n4-(6-methoxy-8-quinolinyl)- (9ci) but generally known as pamaquine, which bears us nih compound identifier 10290. european medicines agency schedules pamaquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09595mig. the term pamaquine is an international non-proprietary name. pamaquine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pamaquine under hs 29334990 and sitc 51575. as of q4 2014, pamaquine remains the us fda preferred term for this commodity. pamaquine bears us nlm identifiers umls id c0069991 and nci concept code c73003. smiles: o(c1cc(nc(cccn(cc)cc)c)c2ncccc2c1)c.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. sitamaquine. this classification denotes an antiprotozoal agent with the molecular formula c21h33n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5aij4tgc6b, chemically known as 1,6-hexanediamine, n,n-diethyl-n-(6-methoxy-4-methyl-8-quinolinyl)- but generally known as sitamaquine, which bears us nih compound identifier 42548. european medicines agency schedules sitamaquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub37607. the term sitamaquine is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). most nations schedule sitamaquine under hs 29334990 and sitc 51575. as of q4 2014, sitamaquine remains the us fda preferred term for this commodity. sitamaquine bears us nlm identifiers umls id c1099477 and nci concept code c73010. smiles: o(c1cc(nccccccn(cc)cc)c2nccc(c2c1)c)c.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. tafenoquine. this classification denotes an antimalarial agent with the molecular formula c24h28f3n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 262p8gs9l9, chemically known as 1,4-pentanediamine, n4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)- but generally known as tafenoquine, which bears us nih compound identifier 115358. european medicines agency schedules tafenoquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04666mig. the term tafenoquine is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). most nations schedule tafenoquine under hs 29334990 and sitc 51575. as of q4 2014, tafenoquine remains the us fda preferred term for this commodity. tafenoquine bears us nlm identifiers umls id c0903411 and nci concept code c73006. smiles: fc(f)(f)c1cc(oc2c3c(nc(oc)cc3c)c(nc(cccn)c)cc2oc)ccc1.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. tebuquine. this classification denotes an antimalarial agent with the molecular formula c26h25cl2n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 699q1xt4en, chemically known as wr 228,258 but generally known as tebuquine, which bears us nih compound identifier 71991. european medicines agency schedules tebuquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10855mig. the term tebuquine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). tebuquine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tebuquine under hs 29334990 and sitc 51575. as of q4 2014, tebuquine remains the us fda preferred term for this commodity. tebuquine bears us nlm identifiers umls id c0144939 and nci concept code c75270. smiles: clc1ccc(c2c(o)c(cnc(c)(c)c)cc(nc3c4c(ncc3)cc(cl)cc4)c2)cc1.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. acediasulfone. this classification denotes an antibiotic with the chemical formula c14h14n2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 30yp2yhh8w, chemically known as n-[4-[(4-aminophenyl)sulfonyl]phenyl]glycine, but which is more commonly know as acediasulfone. european medicines agency schedules acediasulfone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00242mig. the term acediasulfone is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4.) as of q4 2014, acediasulfone remains the us fda preferred term for this commodity. acediasulfone bears us nlm identifiers umls id c1958507 and nci concept code c77129. smiles: c1=cc(=cc=c1n)s(=o)(=o)c2=cc=c(c=c2)ncc(=o)o.. "
"antiprotozoals. this classification denotes agents used in the treatment of malaria, a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum, plasmodium vivax, plasmodium ovale, and plasmodium malariae, and transmitted by the bite of an infected female mosquito of the genus anopheles. malaria is endemic in parts of asia, africa, central and south america, oceania, and certain caribbean islands. it is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.. cycloguanil embonate. this classification denotes an antimalarial and folic acid antagonist with the molecular formula c23h16o6.2c11h14cln5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tco0sy4n3d, chemically known as 4,6-diamino-1-(p-chlorophenyl)-1,2-dihydro-2,2-dimethyl-s-triazine pamoate but more generally known as cycloguanil embonate, which bears us nih compound identifier 11870. european medicines agency schedules cycloguanil embonate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06853mig. world health organization schedules cycloguanil embonate in its anatomical therapeutic chemical (atc) classification. most nations schedule cycloguanil embonate under hs 29336980 and sitc 51576. smiles: cc1(n=c(n=c(n1c2ccc(cc2)cl)n)n)c.cc1(n=c(n=c(n1c2ccc(cc2)cl)n)n)c.c1ccc2c(c1)cc(c(c2cc3c4ccccc4cc(c3o)c(=o)o)o)c(=o)o. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. . "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. allantoin/aminacrine/dienestrol/sulfanilamide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu300. this va drug class (gu300) classifies this compound as belonging to the group anti-infectives, vaginal.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. acetic acid/aluminum acetate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot109. this va drug class (ot109) classifies this compound as belonging to the group anti-infectives, topical otic other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. acetic acid/benzalkonium chloride/chloroxylenol/pramoxine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot109. this va drug class (ot109) classifies this compound as belonging to the group anti-infectives, topical otic other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. acetic acid/benzalkonuim chloride/chloroxylenol/glycerin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot109. this va drug class (ot109) classifies this compound as belonging to the group anti-infectives, topical otic other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. acetic acid/benzethonium chloride/propylene glycol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot109. this va drug class (ot109) classifies this compound as belonging to the group anti-infectives, topical otic other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. acetic acid/benzethonium/propylene glycol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot109. this va drug class (ot109) classifies this compound as belonging to the group anti-infectives, topical otic other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. acetic acid/desonide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot250. this va drug class (ot250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical otic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. acetic acid/hydrocortisone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot250. this va drug class (ot250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical otic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. acetic/benzalkonium/parachlorometoxylenol/pramoxine/propylene. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot109. this va drug class (ot109) classifies this compound as belonging to the group anti-infectives, topical otic other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. alkyl/aminacrine/benzoxiquine/cupric/edetate/sodium. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu300. this va drug class (gu300) classifies this compound as belonging to the group anti-infectives, vaginal.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. bacitracin/hydrocortisone/neomycin/polymyxin b. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op350. this va drug class (op350) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical ophthalmic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. allantoin/aminacrine/sulfanilamide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu300. this va drug class (gu300) classifies this compound as belonging to the group anti-infectives, vaginal.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. allantoin/aminacrine/sulfisoxazole. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu300. this va drug class (gu300) classifies this compound as belonging to the group anti-infectives, vaginal.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. aloe/hydrocortisone/iodoquinol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. aluminum acetate/benzethonium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. aminacrine/docusate/edetate sodium/nonoxynol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu300. this va drug class (gu300) classifies this compound as belonging to the group anti-infectives, vaginal.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. amphotericin b/tetracycline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am900. this va drug class (am900) classifies this compound as belonging to the group anti-infectives, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. bacitracin/diperodon/neomycin/polymyxin b. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. betamethasone/clotrimazole. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. bacitracin/neomycin/polymyxin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. bacitracin/neomycin/polymyxin b. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. bacitracin/polymyxin b. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. bacitracin/polymyxin b/pramoxine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. benzalkonium chloride/chloroxylenol/hydrocortisone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot250. this va drug class (ot250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical otic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. benzalkonium/oxyquinoline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. ciprofloxacin/dextrose. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am900. this va drug class (am900) classifies this compound as belonging to the group anti-infectives, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. brilliant green/gentian violet/proflavine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. cetylpyridinium chloride/chloroxylenol/hydrocortisone/triacetin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. cetylpyridinium chloride/dyclonine hydrochloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. cetylpyridinium/chloroxylenol/triacetin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. chloramphenicol/hydrocortisone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op350. this va drug class (op350) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical ophthalmic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. chloramphenicol/hydrocortisone/polymyxin b. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op350. this va drug class (op350) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical ophthalmic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. chlorcyclizine/hydrocortisone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. chloroxylenol/isopropyl myristate/undecylenic acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. ciprofloxacin/dexamethasone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot250. this va drug class (ot250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical otic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. dexamethasone/tobramycin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op350. this va drug class (op350) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical ophthalmic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. ciprofloxacin/hydrocortisone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot250. this va drug class (ot250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical otic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. clioquinol/hydrocortisone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. clioquinol/hydrocortisone/pramoxine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. colistin/hydrocortisone/neomycin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot250. this va drug class (ot250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical otic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. colistin/hydrocortisone/neomycin/thonzonium. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot250. this va drug class (ot250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical otic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. dalfopristin/quinupristin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am900. this va drug class (am900) classifies this compound as belonging to the group anti-infectives, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. dexamethasone/neomycin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. dexamethasone/neomycin/polymyxin b. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op350. this va drug class (op350) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical ophthalmic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. hydrocortisone/neomycin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. erythromycin/sulfisoxazole. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am900. this va drug class (am900) classifies this compound as belonging to the group anti-infectives, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. fluocinolone/neomycin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. fluorometholone/sulfacetamide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op350. this va drug class (op350) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical ophthalmic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. flurandrenolide/neomycin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. gentamicin/prednisolone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op350. this va drug class (op350) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical ophthalmic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. gramicidin/neomycin/nystatin/triamcinolone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. gramicidin/neomycin/polymyxin b. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op219. this va drug class (op219) classifies this compound as belonging to the group anti-infective, topical ophthalmic, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. hexachlorophene/hydrocortisone/menthol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. hydrocortisone/iodoquinol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. metronidazole/sodium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am900. this va drug class (am900) classifies this compound as belonging to the group anti-infectives, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. hydrocortisone/neomycin/polymyxin b. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. hydrocortisone/oxytetracycline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op350. this va drug class (op350) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical ophthalmic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. hydrocortisone/polymyxin b. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ot250. this va drug class (ot250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical otic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. isopropyl alcohol/salicylic acid/sodium thiosulfate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. loteprednol/tobramycin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op350. this va drug class (op350) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical ophthalmic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. methylprednisolone/neomycin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. oxytetracycline/polymyxin b. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. neomycin/polymyxin b. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. neomycin/polymyxin b/prednisolone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op350. this va drug class (op350) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical ophthalmic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. neomycin/polymyxin/pramoxine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de109. this va drug class (de109) classifies this compound as belonging to the group anti-infective, topical, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. neomycin/prednisolone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. nystatin/oxytetracycline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am900. this va drug class (am900) classifies this compound as belonging to the group anti-infectives, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. nystatin/triamcinolone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de250. this va drug class (de250) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. oxytetracycline/phenazopyridine/sulfamethizole. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am900. this va drug class (am900) classifies this compound as belonging to the group anti-infectives, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. polymyxin b/trimethoprim. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op219. this va drug class (op219) classifies this compound as belonging to the group anti-infective, topical ophthalmic, other.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. prednisolone/sulfacetamide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class op350. this va drug class (op350) classifies this compound as belonging to the group anti-infective/anti-inflammatory combinations, topical ophthalmic.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. sulfabenzamide/sulfacetamide/sulfathiazole. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu300. this va drug class (gu300) classifies this compound as belonging to the group anti-infectives, vaginal.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. sulfabenzamide/sulfacetamide/sulfathiazole/urea. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu300. this va drug class (gu300) classifies this compound as belonging to the group anti-infectives, vaginal.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. ambroxol/amoxicllin. this classification denotes a combination drug composed of two constituents: a mucolytic and an aminopenicillin, as more fully appears. the first constituent, ambroxol (51162702) is an expectorant and amino-alcohol that bears the molecular formula c13h18br2n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 200168s0cl, chemically known as 4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol but more generally known as ambroxol [eu/esis 242-500-3]; ambroxol comes in forms acefyllinate [0hm1e174tn], base, and hydrochloride [cc995zmv90]. european medicines agency schedules ambroxol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05397mig (base), sub12842mig (acefyllinate), and sub00427mig (hydrochloride). the term ambroxol is an international non-proprietary name or inn. world health organization schedules ambroxol in its anatomical therapeutic chemical (atc) classification (r05cb06) and in its who drug dictionary. ambroxol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ambroxol under hs 29221980 and sitc 51461. us census, for industry purposes, classifies ambroxol under naics 325199. the second constituent in this preparation is amoxicillin {51281702}, a penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 804826j2hu. amoxicillin comes in forms anhydrous, hydrate, sodium, and trihydrate {51281710, 51281711, 51281712, 51281713}. european medicines agency schedules amoxicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05481mig. amoxicillin generally arises in the molecular formula c16h19n3o5s. the term amoxicillin is a european pharmacopoeia designation. amoxicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amoxicillin under hs 29411010 and sitc 54131. as of q4 2014, amoxicillin remains the us fda preferred term for this commodity. amoxicillin bears us nlm identifiers umls id c0002645 and nci concept code c237. practitioners typically use this combination drug in treatment of chronic bronchitis and similar maladies.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. ambroxol/cefadroxil. this classification denotes a combination drug composed of two constituents: a mucolytic and a cephalosporin antibiotic, as more fully appears. the first constituent, ambroxol (51162702), is an expectorant and amino-alcohol that bears the molecular formula c13h18br2n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 200168s0cl, chemically known as 4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol but more generally known as ambroxol [eu/esis 242-500-3]; ambroxol comes in forms acefyllinate [0hm1e174tn], base, and hydrochloride [cc995zmv90]. european medicines agency schedules ambroxol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05397mig (base), sub12842mig (acefyllinate), and sub00427mig (hydrochloride). the term ambroxol is an international non-proprietary name or inn. world health organization schedules ambroxol in its anatomical therapeutic chemical (atc) classification (r05cb06) and in its who drug dictionary. ambroxol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ambroxol under hs 29221980 and sitc 51461. us census, for industry purposes, classifies ambroxol under naics 325199. the second constituent, cefadroxil (51282502), is a cephalosporin antibiotic with the molecular formula c16h17n3o5s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 280111g160, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6-alpha,7-beta(r*)))- but generally known as cefadroxil, which bears us nih compound identifier 2610. cefadroxil most often comes in base, hydrate, and hemihydrate forms. european medicines agency schedules cefadroxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06164mig. world health organization schedules cefadroxil in its anatomical therapeutic chemical (atc) classification. cefadroxil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefadroxil under hs 29419000 and sitc 54139. as of q4 2014, cefadroxil remains the us fda preferred term for this commodity. cefadroxil bears us nlm identifiers umls id c0007538 and nci concept code c28912.. "
"combination anti-infectives. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection, hence the term anti-infectives. the us national library of medicine includes, under this general heading, a wide variety of agents, including anti-bacterials, antifungals, antiparasitics, antivirals, and disinfectants. typical combination anti-infective constituents are acetic acid, benzalkonium, cetylpyridinium, hexachlorophene, and isopropyl alcohol.. ambroxol/clarithromycin. this classification denotes a combination drug composed of two constituents: a mucolytic and a macrolide antibiotic, as more fully appears. the first constituent, ambroxol (51162702), is an expectorant and amino-alcohol that bears the molecular formula c13h18br2n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 200168s0cl, chemically known as 4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol but more generally known as ambroxol [eu/esis 242-500-3]; ambroxol comes in forms acefyllinate [0hm1e174tn], base, and hydrochloride [cc995zmv90]. european medicines agency schedules ambroxol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05397mig (base), sub12842mig (acefyllinate), and sub00427mig (hydrochloride). the term ambroxol is an international non-proprietary name or inn. world health organization schedules ambroxol in its anatomical therapeutic chemical (atc) classification (r05cb06) and in its who drug dictionary. ambroxol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ambroxol under hs 29221980 and sitc 51461. us census, for industry purposes, classifies ambroxol under naics 325199. the second component of this combination drug, clarithromycin(51282302), is a macrolide antibiotic with the molecular formula c38h69no13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h1250jik0a, chemically known as erythromycin, 6-o-methyl- but generally known as clarithromycin {51282302}, which bears us nih compound identifier 54688. european medicines agency schedules clarithromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06641mig. the term clarithromycin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules clarithromycin in its anatomical therapeutic chemical (atc) classification. clarithromycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clarithromycin under hs 29415000 and sitc 54139. as of q4 2014, clarithromycin remains the us fda preferred term for this commodity. clarithromycin bears us nlm identifiers umls id c0055856 and nci concept code c1054.. "
"combination antimalarials. this classification denotes combination drugs that treat a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum; plasmodium vivax; plasmodium ovale; and plasmodium malariae; and transmitted by the bite of an infected female mosquito of the genus anopheles, a disease called malaria, and hence the term antimalarials. typical combination antimalarial constituents are artemether, atovaquone, chloroquine, and pyrimethamine.. . "
"combination antimalarials. this classification denotes combination drugs that treat a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum; plasmodium vivax; plasmodium ovale; and plasmodium malariae; and transmitted by the bite of an infected female mosquito of the genus anopheles, a disease called malaria, and hence the term antimalarials. typical combination antimalarial constituents are artemether, atovaquone, chloroquine, and pyrimethamine.. artemether/lumefantrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ap101. this va drug class (ap101) classifies this compound as belonging to the group antimalarials.. "
"combination antimalarials. this classification denotes combination drugs that treat a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum; plasmodium vivax; plasmodium ovale; and plasmodium malariae; and transmitted by the bite of an infected female mosquito of the genus anopheles, a disease called malaria, and hence the term antimalarials. typical combination antimalarial constituents are artemether, atovaquone, chloroquine, and pyrimethamine.. atovaquone/proguanil. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ap101. this va drug class (ap101) classifies this compound as belonging to the group antimalarials.. "
"combination antimalarials. this classification denotes combination drugs that treat a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum; plasmodium vivax; plasmodium ovale; and plasmodium malariae; and transmitted by the bite of an infected female mosquito of the genus anopheles, a disease called malaria, and hence the term antimalarials. typical combination antimalarial constituents are artemether, atovaquone, chloroquine, and pyrimethamine.. chloroquine/primaquine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ap101. this va drug class (ap101) classifies this compound as belonging to the group antimalarials.. "
"combination antimalarials. this classification denotes combination drugs that treat a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum; plasmodium vivax; plasmodium ovale; and plasmodium malariae; and transmitted by the bite of an infected female mosquito of the genus anopheles, a disease called malaria, and hence the term antimalarials. typical combination antimalarial constituents are artemether, atovaquone, chloroquine, and pyrimethamine.. pyrimethamine/sulfadoxine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ap101. this va drug class (ap101) classifies this compound as belonging to the group antimalarials.. "
"combination pediculicides. this classification denotes combination drugs and preparations that kill lice or pediculus humanus capitus, hence the term pediculicides. typical combination pediculicide constituents are piperonyl butoxide and pyrethrins.. . "
"combination pediculicides. this classification denotes combination drugs and preparations that kill lice or pediculus humanus capitus, hence the term pediculicides. typical combination pediculicide constituents are piperonyl butoxide and pyrethrins.. petroleum/piperonyl butoxide/pyrethrins. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ap300. this va drug class (ap300) classifies this compound as belonging to the group pediculicides.. "
"combination pediculicides. this classification denotes combination drugs and preparations that kill lice or pediculus humanus capitus, hence the term pediculicides. typical combination pediculicide constituents are piperonyl butoxide and pyrethrins.. piperonyl butoxide/pyrethrins. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ap300. this va drug class (ap300) classifies this compound as belonging to the group pediculicides.. "
"combination pediculicides. this classification denotes combination drugs and preparations that kill lice or pediculus humanus capitus, hence the term pediculicides. typical combination pediculicide constituents are piperonyl butoxide and pyrethrins.. piperonyl butoxide/pyrethrins/petroleum distillates. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ap300. this va drug class (ap300) classifies this compound as belonging to the group pediculicides.. "
